EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Quantitative Systems Toxicology Modeling of Acetaminophen Pharmacokinetics and Hepatic Biomarkers After Overdoses of Extended‐Release and Immediate‐Release Formulations in Adults With Chronic Alcohol Use or Low Glutathione

Kyunghee Yang iD, James J Beaudoin iD, Brett A Howell iD, James Mullin, Elham Amini, John C K Lai, Cathy K Gelotte iD, Sury Sista, Evren Atillasoy iD

CPT: Pharmacometrics & Systems Pharmacology · 2025

DOI: 10.1002/psp4.70045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Kyunghee Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative Systems Pharmacology Solutions, Simulations Plus Inc., Research Triangle Park, North Carolina, USA. Hauptthemen laut MEDLINE: Acetaminophen, Glutathione, Drug Overdose, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetaminophen (APAP), an over‐the‐counter analgesic and antipyretic, can cause hepatotoxicity when ingested in large overdoses. APAP has multiple formulations including immediate‐release (IR) and extended‐release (ER) preparations. A recently published consensus statement on the management of APAP poisoning indicated that management of APAP‐ER overdose is the same as that for APAP‐IR overdose. Consistent with this consensus, it was previously reported that quantitative systems toxicology (QST) modeling using DILIsym predicted similar pharmacokinetic (PK) and hepatic biomarker profiles for the APAP‐ER and APAP‐IR formulations after overdose in healthy adults. Hepatic injury from APAP is caused by the reactive metabolite, N‐acetyl‐ρ‐benzoquinone imine (NAPQI), which is formed predominantly by CYP2E1‐mediated metabolism and eliminated by hepatic glutathione. As such, conditions that can increase NAPQI production (e.g., CYP2E1 induction by alcohol) or decrease hepatic glutathione stores (e.g., underling liver disease) may impact PK and susceptibility to hepatotoxicity after overdose of APAP‐IR and APAP‐ER. In the current study, APAP‐IR and APAP‐ER models in chronic alcohol users and individuals with low hepatic glutathione were developed and verified within DILIsym. Simulations using verified models predicted similar PK and hepatic biomarker profiles for the APAP‐ER and APAP‐IR formulations in moderate and excessive chronic alcohol users and adults with low hepatic glutathione levels after single acute overdoses up to ~100 g and repeat supratherapeutic ingestions (up to 7.8 g/day for 10 days). These results further support that approaches to manage APAP‐IR overdoses can be applied to manage APAP‐ER overdoses in adults with chronic alcohol consumption or lower hepatic glutathione levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenGlutathioneDrug OverdoseChemical and Drug Induced Liver InjuryAnalgesics, Non-NarcoticLiverAlcoholismHumansAdultBiomarkersDelayed-Action PreparationsMaleModels, BiologicalFemaleMiddle AgedCytochrome P-450 CYP2E1Young AdultIminesBenzoquinones

Stichwörter der Autor:innen

acetaminophenextended releaseliver safetyquantitative systems toxicology modeling

Substanzen

AcetaminophenGlutathioneBiomarkersDelayed-Action PreparationsAnalgesics, Non-NarcoticN-acetyl-4-benzoquinoneimineCytochrome P-450 CYP2E1IminesBenzoquinones

Autor:innen und Institutionen

  • Quantitative Systems Pharmacology Solutions, Simulations Plus Inc., Research Triangle Park, North Carolina, USA.
  • Physiologically-Based Pharmacokinetics Solutions, Simulations Plus Inc., Research Triangle Park, North Carolina, USA.
  • Kenvue, Summit, New Jersey, USA.
  • Independent Consultant, Westbrook, Connecticut, USA.

ORCID-Profile: Kyunghee Yang, James J Beaudoin, Brett A Howell, Cathy K Gelotte, Evren Atillasoy

Zitieren

APA

Yang, K., Beaudoin, J. J., Howell, B. A., Mullin, J., Amini, E., Lai, J. C. K., Gelotte, C. K., Sista, S., & Atillasoy, E. (2025). Quantitative Systems Toxicology Modeling of Acetaminophen Pharmacokinetics and Hepatic Biomarkers After Overdoses of Extended‐Release and Immediate‐Release Formulations in Adults With Chronic Alcohol Use or Low Glutathione. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70045

Vancouver

Yang K, Beaudoin JJ, Howell BA, Mullin J, Amini E, Lai JCK, et al. Quantitative Systems Toxicology Modeling of Acetaminophen Pharmacokinetics and Hepatic Biomarkers After Overdoses of Extended‐Release and Immediate‐Release Formulations in Adults With Chronic Alcohol Use or Low Glutathione. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.70045

BibTeX
@article{Yang2025,
  author = {Yang, Kyunghee and Beaudoin, James J and Howell, Brett A and Mullin, James and Amini, Elham and Lai, John C K and Gelotte, Cathy K and Sista, Sury and Atillasoy, Evren},
  title = {Quantitative Systems Toxicology Modeling of Acetaminophen Pharmacokinetics and Hepatic Biomarkers After Overdoses of Extended‐Release and Immediate‐Release Formulations in Adults With Chronic Alcohol Use or Low Glutathione},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2025},
  doi = {10.1002/psp4.70045}
}
Kostenlos starten →